The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space.
Glycostem attends the 2nd Annual Cell & Gene Therapy Manufacturing conference virtually. Our CEO Troels Jordansen shares Glycostem world’s first off-the-shelf NK cell-based immunotherapy in the fight against cancer.
Glycostem participates the 7th Solebury Trout Private Company Showcase co-hosted by BMO and Davis Polk. Glycostem CEO Troels Jordansen presents virtually on Thursday 15th Oct 2020, with featured presentation and Q&A session.
Glycostem CEO Troels Jordansen shares updates from Glycostem at Alliance for Regenerative Medicine’s 2020 Cell & Gene Virtual Meeting on the Mesa.